DrugDashboards

Market view

ciclesonide · Inhalant

1 marketed package NDCs · 1 active manufacturer

Most dispensed: 160 ug · Aerosol, Metered · #1 inhaler/carton / 60 aerosol, metered in 1 inhaler · 80 ug · Aerosol, Metered · #1 inhaler/carton / 60 aerosol, metered in 1 inhaler · 50 ug · Spray · #1 pouch/carton / 1 bottle, glass in 1 pouch / 120 spray in 1 bottle, glass

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

What changed in the last 90 days

Every detected change for ciclesonide, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

  • AlvescoAug 19, 2026
    Price down
    NADAC $43.00308 → $42.97348 per unit (-0.07%)
  • AlvescoAug 19, 2026
    Price down
    NADAC $42.97124 → $42.9537 per unit (-0.04%)
  • OmnarisAug 19, 2026
    Price down
    NADAC $22.56769 → $22.56359 per unit (-0.02%)
  • OmnarisJul 22, 2026
    Price up
    NADAC $22.5584 → $22.56769 per unit (+0.04%)
  • AlvescoJul 22, 2026
    Price up
    NADAC $42.96934 → $42.97124 per unit (0%)
  • AlvescoJul 22, 2026
    Price up
    NADAC $43.00155 → $43.00308 per unit (0%)

Common questions

Is Ciclesonide in shortage right now?
No. FDA does not currently list Ciclesonide in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Ciclesonide?
5 companies have marketed Ciclesonide in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
What does Ciclesonide cost?
The typical pharmacy pays about $42.95 per gram, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.